This paper introduces an equilibrium approach by assuming that the underlying (motrality rate) has transformed normal distribution to price the Swiss Re mortality bond in a discrete time economy. Our study assumes a general distribution, which is more plausible for valuating mortality-linked securities when the distributions of mortality rate are highly skew. The valuation relationship is still risk-neutral (preference-free) and the mortality bond is priced as the expected value of its terminal payo¤, discounted by the riskfree rate. This pricing rule complements current researches on the valuation of mortality-linked securities, which may only exists discrete trading opportunities and insu¢ cient market trading data. Finally, this study gives a closed-form solution for pricing the Swiss Re mortality bond. The mortality bond is a good deal for the investors if the default risk and premium fees can be ignored.
Introduction
Longevity and mortality catastrophe risk has created new challenges for …nancial intermediations, especially for life insurers, reinsurers, annuity providers, and pension funds. This risk is systematic, long-trend, and widespread all over the world. To mitigate uncertain losses, the insurance industry has begun to securitize mortality-related exposures to capital markets. We name these securities as mortality-linked contingent claims (MLCCs).
The related literature for developing valuation methods on MLCCs has grown rapidly in recent years. Two main valuation approaches are the Wang transform (Wang, 2000 (Wang, , 2002 and arbitrage-free pricing of Cairns, Blake, and Dowd (2006b). Wang's approach provides a distortion operator that transforms the underlying distribution to an equivalent risk-adjusted one, applied to discount the expected cash ‡ows with a risk-free rate. Lin and Cox (2005) and Cox, Lin and Wang (2006) use this approach to successfully price the Swiss Re survivor bond. Denuit, Devolder, and Goderniaux (2007) used a similar treatment on the Lee-Carter mortality process to price Survivor bonds.
The approach of Cairns et al. (2006b) uses the arbitrage-free principle to price the European Investment Bank (EIB) longevity bond in an incomplete market setting. Their arbitrage-free pricing approach states that if the market is arbitrage free, there exist one risk-neutral measure Q to calculate fair prices. They assume that the market price of longevity risk is constant and estimate it from the longevity risk premium, implied by the proposed issue price of the EIB longevity bonds. Milevsky The concern in this paper is that the MLCC market may only exist discrete trading opportunity and the replicated payo¤ of MLCCs can not be formed. Besides, up to now, su¢ cient transaction data in the MLCC market is not available. These market structure and restrictions inspire us a third approach to price the MLCCs. Rubinstein (1976) and Brennan (1979) propose the valuation relationship in a equilibrium setting that expected cash ‡ow of contingent claims to be discounted at a risk-free rate and is named as risk neutral valuation relationship (RNVR). They also derived the option pricing formulation by assuming that the representative agent has a CRRA/CARA preference; aggregate wealth and underlyings have a joint lognormal/joint normal distribution. Their pricinig formula is the same to the Black-Scholes model (1973) and also preference-free. Doherty and Garven (1986) followed their insights to derive the fair rate of return for the property-liability insurance company. Their results work, depending on the triplet assumptions (preference, wealth, and underlying distributions) and do not require transaction data. Therefore, following their framework, we provide another valua-tion approach to price MLCCs that is di¤erent to Wang's transform and the no-arbitrage method.
One problem in applying the RNVR approach to price MLCCs is that the underlying assets may not be lognormal or normal distributions when longevity risk and catastrophe risk accompany the mortality process. Lin and Cox (2008) showed that when mortality processes with jumps, the terminal loss distribution tends toward positive skew (cf. Lin and Cox, 2008) . This article introduces a transformed normal distribution to accommodate high-order moments of mortality risk, especially catastrophe risk, to the MLCCs. The transformed normal distribution includes lognormal and skew lognormal, and the S U system can have negative, zero, or positive skewness and is more leptokurtic than the lognormal distribution (Johnson (1949) and Johnson, Kotz, and Balakrishnan (1994) ). The transformed normal distribution still keeps the RNVR property and the Black-Scholestype option pricing formula, shown by Camara (2003) . With this generalization, we can price MLCCs with a more plausible distributional assumption and devote attention to the high-order moments of mortality risk. We give an example on pricing the Swiss Re mortality bond in Section 4.
Under the triplet assumptions, we use the RNVR for arbitrary MLCCs and their prices are the expected end-of-period payo¤s discounted at risk-free rate, taken with respect to the risk-neutral transformed normal density. These results are valuable for current MLCC studies in at least three aspects. First, we …nd the convenient pricing rule in a equilibrium model, which may only exists discrete trading opportunity and insu¢ cient market transaction data. Second, we could include the default risk as limited liability in option pricing model, which may be crucial in the securitization market. Third, we keep the high-order moments of the original (physical) distribution in the valuation formula, information important for MLCCs valuation. The meaning of transform in our approach is di¤erent to Wang's transform, which distorts the original distribution, but we do not. We assume the distribution in a general form that can be transformed into a normal distribution without changing the underlying distribution.
The remainder of this article is organized as follows: Section 2 sets the valuation methods in a discrete time economy, including decomposition of the Swiss Re mortality bond, the valuation methods, and how the RNVR is obtained. Section 3 introduces the risk-neutral valuation approach to price the Swiss Re mortality bond with speci…ed underlying distributions. We derived the colsed-form formualtion under transformed normal distribution. By means of the simulated mortality distribution, Section 4 determine the price of price the Swiss Re mortality bond. An simple approach are provided to esitmate the transformed normal distribution and their parameters. Section 5 o¤ers some conclusions and implications. The Swiss Re insurance Company issued a three-year mortality bond in December 2003, through a special purpose vehicle (SPV), Vita Capital. The total amount was $400 million and bondholders receive coupons quarterly at a rate of three-month U.S. dollar LIBOR plus 135 basis points. The principle is not fully protected and is dependent on the mortality index weighted by …ve countries'mortality experiences. 1 If the mortality index q t exceeds the 130% of the 2002 level q 0 , the principal loss will increase 5% for every 1% raise in the index. If q t exceeds 150% of q 0 , the principal is exhausted. The percentage loss of principal in year t, can be described as:
The principal paid back to the bondholders at maturity is:
where t = 1, 2, 3 for year 2003, 2004 and 2005, respectively. Figure 1 draws the payo¤ pattern of the principal on t =1. Figure 1 (a) shows that the principal loss is in form of a bear spread depending on mortality level. As we known, the bear spread can be replicated by buying a call option with one strike price and selling another call option with di¤erent strike price. Thus the principle loss at t = 1 of the mortality bond can be formulated by two call options:
If we …nd the value of these calls, we …nd the value of L 1 : Similarly, the principle loss at t = 2, L 2 has the same exercise price but with a newer mortality level. Replacing q 1 by q 2 in equation (3), we obtain L 2 : Again, L 3 can also be obtained by replacing q 1 with q 3 in equation (3) . The cumulated loss percentage will be
We can …nd the terminal principal value at time 0 with some proper discounting:
where P V is the present value operator. Section 4 uses equation (4) 
where q max = M ax(q 1 ; q 2 ; q 3 ). Since the probability of two mortality catastrophes at sequence-years are rare, they choose the maximum value of q t for a representative mortality level. This simpli…cation gives a snapshot of a muti-period valuation as single-period one. For more details, please see Chen and Cox (2009) . In Section 4, we uses both method (with and without approximation) to price the principle of the Swiss Re mortality bond.
General Equilibrium Pricing Model
This subsection reviews the equilibrium pricing on the contingent claims with uncertain payo¤s. Let E P [ ] be the expected value operator under the actual probability measure, and U 0 and U 1 are the utility function of a representative investor over the consumptions. The current consumption is C 0 ; initial wealth and the end-of-period wealth are W 0 and
is the current price of security j written on the underlying q: P j1 (q) is the payo¤ of the security j written on the underlying q at the end-of-period. The demand for the securities is y j : Assume that the representative agent is non-satiated and risk-averse. By maximizing his expected utility:
M ax
Co; y j
and following the equilibrium condition, we have
where W 1 = (W 0 C 0 ) e r + P n j=1 y j (P j1 (q) P j0 e r ) and (q) is pricing kernel de…ned as:
Equation (6) states the price of any security may be expressed as the expected value product by its relative conditional marginal utility of wealth and discounted at the riskfree interest rate. Speci…cally, throughout the rest of this article, we focus on one underlying (i.e., mortality rate) and one contingent claim written on it. Then, the subscripts j in equation (6) can be suppressed and rewritten as:
In equation (8) , the price relationship is still preference-dependence.
Risk Neutral Valuation Relationships
To analyze the expected value of equation (8), we need to specify the distributions of terminal wealth, underlying asset, and represent agent's utility. Camara (2003) propose the transformed-normal distribution: Definition The transformed normal distribution are de…ned by the transformation of random variable q such that:
where ; ; and are parameters ( ; > 0) and f is a strictly monotonic di¤erential function. N ( ; 2 ) is a normal distribution with mean and variance 2 :
This de…nition is identical to the four-parameter transformed normal distribution of Johnson (1949) and Johnson, et al. (1994) , but slightly di¤erent to the three-parameter transformed normal distribution of Camara (2003) . We adapt Johnson's de…nition because we …nd it have a better …tting result than Camara's de…nition in our mortality data. Transformed normal distribution are much more general than normal distribution. There are some well-known distribution can be included in transformed normal distribution. For example, if = 0; = 1 and f is log function, then q is a lognormal distribution. If q > > 0; = 1 and f is log function then q is a skew lognormal distribution.
Assume the terminal wealth W 1 and underlying q have a joint distribution:
where f and f 1 are a strictly monotonic di¤erentiable function as de…ned in equation (9), N denotes the bivariate normal distribution with means w and ; standard deviations w and ; and correlation coe¢ cient : The subscripts w denotes the parameters for the wealth. The marginal utility of the represent agent is in the form:
where is constant and f is the same one as in equation (10) . Following the assumption of (10) and (11), the equilibrium price is:
where E Q [ ] is the expected value operator under the Q probability measure with respect to the risk-neutral transformed normal density. 2 This risk-neutral density has a shifted location of the underlying density and does not relate to preference parameters. Therefore, the value of the contingent claim is the expected cash ‡ow of P 1 (q) discounted by risk-free rate. We now have a RNVR to price MLCCs and discount their future contingent payo¤ by the risk-free rate. This RAVR places restrictive assumptions on the underlying distribution, individual wealth, and preference. The no-arbitrage pricing does not need such assumptions. However, when a replicated portfolio is not available and lacking of trading data for MLCCs, equilibrium pricing still provides information. The transformed normal distribution keeps high-order moments in the pricing formula, such as skewness. The next section shows that the high-order moments a¤ect the valuations.
Valuation of The Swiss Re Mortality Bond

Speci…cations of underlying distribution
In this section, we present some more speci…c distribution of transformed normal distribution that lead to closed-form solutions as Black-Scholes-type formula for the Swiss Re Mortality Bond. We assume q follow (a) S U distribution, (b) skewed lognormal distribution and (c) lognormal distribution and derive their corresponding pricing formula.
(a) Assume that aggregate wealth has a lognormal distribution; the mortality rate q follows the S U system developed by Johnson (1949) and representative agent has a power utility function displaying constant relative risk aversion (CRRA). Thus f (W 1 ) = ln (W 1 ) and f 1 (q) = sinh 1 (
where and are positive constants. With the terminal payo¤ M ax(q K; 0); the option price at t = 0 is: where
and ( ) is cumulated standard normal distrubution. Proof: see Appendix A.
(b) Assume that the aggregate wealth has normal distribution, the mortality rate q t has a skewed lognormal distribution, and the agent has a negative exponential preferences. Thus f (W 1 ) = W 1 and f 1 (q t ) = ln(q ) where is a positive constant. With the terminal payo¤ M ax(q K; 0); the option price is
where
We show the proof in Appendix B.
Parameter Estimation and Option Pricing
In this section, we use several stochastic mortality processes to generate the terminal distribution of q. These include Lee-Carter with jumps model (Chen and Cox, 2009) , and the catastrophe model of Lin and Cox (2008) . We obtained our mortality data from the National Center for Health Statistics (NCHS) 3 . We use this data to generate the mortality distribution from 2003 to 2005, regarding these as discrete distribution at each end-of-year. We estimate the parameters of the distribution according to the transformed normal distribution. The four-parameters transformed normal distribtuion are di¢ cult to estimate in the usual manner. We proposed a quantile-estimation method adapted from Slifker and Shapiro (1980) to facilitate the implementation.
Parameter Estimation for the S U distribution
The Slifker and Shapiro (1980) quantile-based estimation method provides two advantages. One is an increase in the accuracy when the observations of data is large enough. The other advantage is that the estimators are explicit formulations, which is easy to implement. Below, we descript the steps that the parameters were estimated. Consider any data you have on hand: Choose any value z > 0 from a standard normal random variable (for example, choose z = 1): Then the four points z and 3z determine the corresponding value of the raw data. They are q 3z ; q z ; q z and q 3z : Let
If the data passes the criteria of Su distribution, i.e. mn=p 2 > 1; then the estimates for the parameters are: The estimated parameters of mortality data from 2003 to 2005 and q max are shown in the Table 1 . In table 1, we present both the basic statistics and the transformed parameters. In the basic statistics, the row of means shows a decreasing trend from 0.0079608 to 0.0065657. The decreasing trend in mortality rates is a design of Lin and Cox (2008) . Maximum value of the three years, q max shows the greatest mean value, 0.0079698. The row of standard deviations shows an increasing trend from 0.0002845 to 0.00051437, because their model assumes that mortality rate follows geometric Brownian motion and volatility increases with time. However, compared with other years, q max has a smaller standard deviation (0.0002957). We regard the approximation value of mortality rates creates a "censor e¤ect", q max is no longer the largest of the three in standard deviation. Therefore, if standard deviation is crucial to pricing, this approximation method may undervalue the risk. The row of skewness shows a positive skew in the data, with q max showing the greatest degree of skewness.
In and ; are the mean and standard deviation of the normal distribution implying that can be transformed again to obtain standard normal distribution.
Options and mortality bond prices
In this section, we calculate mortality bond price by assuming the underlying transformed normal distribution of the S U system. Initial mortality q 2002 is 0.008758, riskfree interest rate =0.0%
4 , time to maturity= 1 years (3 years for q max ) and exercise prices K 1 = q 2002 1:3 and K 2 = q 2002 1:5. For a better intuition in price, we assumed the principle is 1,000 as opposed to 400 million. Using equation (12) and transformed parameters in Table 1 , the prices of call options and the mortality bond are shown in Table 2 : In Table 2 , the results were derived from two methods. One method used approximation; and the other did not. In the method without approximation, the call prices showed a decreasing trend from 0.020277 to 0.007947 because the mean of q t is decreasing in mean form 2003 to 2005 and the call prices also have a decrease trend form 0.020277 to 0.007947. The exercise price, K 1 is larger than K 2 ; therefore, the value of call 1 was higher than the value of call 2 in each year. Using these call prices and equation (5), we determine principle losses of L t =8.5544, 9.2334, and 4.2915 dollars for each year. Following the relation B 0 = max (1 P t L t ; 0) ; the mortality bond price is 977.92 and par spread is 74 bps.
In the method that used approximation, the mortality bond price is 991.47 and par spread is 29 bps. This spread is smaller than in the method without approximation (74 bps). Comparing our results with other studies, for example, the spread of Lin and Cox (2008) is 39 bps; and the spread of Chen and Cox is 56 bps. In both of these studies, they applied the method with approximation. We believe that the spread was underestimated using the approximation method. However, the Swiss Re o¤eres a spread of 135 bps, which are still greater than the spread in our without approximaton method. We must emphasize that our study does not include default risk or premium fees. Therefore, it is hard to say whether the Swiss Re bonds (with a spread of 135 bps), is a good deal for investors.
Conclusion and Discussion
In this article, we provide an equilibrium pricing approach to value MLCCs and apply it on the Swiss Re mortality bond. An convenient and explicit valuation formulation is obtained. There are several features in this approach. First, relative to the no-arbitrage pricing of Cairns et al. (2006) , we make more restricted assumptions (utility, wealth and underlying distribution). The trade-o¤ is that we do not require market transaction data and replicated portfolio to determine the price of MLCCs. Second, relative to the Wang transform (Wang, 2000 (Wang, , 2002 , the valuation is preference-free and the payo¤ could be discounted at risk-free rate, too. However, our approach does not distort the underlying distribution; we assume a more general distribution that can be transformed into normal distribution. Third, to obtain a better estimation in mortality data, we derive a new option pricing formula for the four-parameter transformed normal distribution, di¤erent from that of Camara (2003) . A quantile-based estimator of S U is applied, to facilitate the estimation process. Finally, the transformed normal distribution enables the inclusion of high-order moments, when the mortality jump is important to the valuation.
Based on the results in our study, we formulate two conclusions. First, the approximation method increases the mean, but decreases the variance of the mortality rate. If the variance is important to the valuation, this method would undervalue the mortality bond price. Second, whether using approximation methods or not, both spreads are smaller than the level o¤ered by Swiss Re. We do not consider the default risk or loading fees, and maybe undervalue the price of the mortality bond. However, if the friction costs of MLCC market is small or could be omitted, it may be that Swiss Re over-compensated mortality bond investors. Substituting q in terms of x, yields the result P e rt = E Q h + sinh x Kj x sinh
Using the de…nition of lognormal distribution, it follows that P e rt = 2 e Q + 
is the same to equation (13) .
Appendix B
